Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 06-2024 | 12-2023 | 06-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,441,000 | 6,795,000 | 8,710,000 | 7,993,000 | 12,736,000 |
| Marketable Securities | 486,000 | N/A | 270,000 | N/A | 664,000 |
| Receivables | 10,629,000 | 8,805,000 | 11,040,000 | 353,000 | 10,746,000 |
| Inventories | 9,431,000 | 10,609,000 | 9,666,000 | 21,630,000 | 8,960,000 |
| Other current assets | 13,706,000 | 3,872,000 | 216,000 | 267,000 | 291,000 |
| TOTAL | $42,588,000 | $30,081,000 | $30,670,000 | $30,243,000 | $34,111,000 |
| Non-Current Assets | |||||
| PPE Net | 11,601,000 | 11,880,000 | 11,814,000 | 11,527,000 | 11,684,000 |
| Investments And Advances | 3,259,000 | 2,640,000 | 2,666,000 | 9,510,000 | 2,765,000 |
| Intangibles | 66,013,000 | 76,733,000 | 73,723,000 | 73,833,000 | 71,532,000 |
| Other Non-Current Assets | 9,337,000 | 8,421,000 | 7,591,000 | 240,000 | 6,630,000 |
| TOTAL | $90,210,000 | $99,674,000 | $95,794,000 | $95,110,000 | $92,611,000 |
| Total Assets | $132,798,000 | $129,755,000 | $126,464,000 | $125,353,000 | $126,722,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,209,000 | 9,236,000 | 2,045,000 | 4,694,000 | 4,174,000 |
| Accounts payable and accrued liabilities | 7,551,000 | 7,433,000 | 7,328,000 | 19,282,000 | 6,813,000 |
| Other current liabilities | 12,547,000 | 12,947,000 | 9,938,000 | 191,000 | 8,108,000 |
| TOTAL | $29,162,000 | $30,027,000 | $24,207,000 | $24,797,000 | $23,974,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,791,000 | 12,503,000 | 14,347,000 | 14,241,000 | 14,857,000 |
| Deferred Revenues | 0 | N/A | 0 | N/A | 264,000 |
| Other Non-Current Liabilities | 9,827,000 | 10,388,000 | 9,632,000 | 9,261,000 | 8,626,000 |
| TOTAL | $25,779,000 | $26,731,000 | $27,904,000 | $27,609,000 | $27,596,000 |
| Total Liabilities | $54,941,000 | $56,758,000 | $52,111,000 | $52,406,000 | $51,570,000 |
| Shareholders' Equity | |||||
| Common Shares | 2,526,000 | 2,533,000 | 2,530,000 | N/A | 2,522,000 |
| Other shareholders' equity | 75,821,000 | 71,211,000 | 72,381,000 | 72,629,000 | 72,843,000 |
| TOTAL | $77,507,000 | $72,690,000 | $74,040,000 | $72,629,000 | $74,784,000 |
| Total Liabilities And Equity | $132,448,000 | $129,448,000 | $126,151,000 | $125,035,000 | $126,354,000 |